Company: CERO
Filing Date: 2025-11-28
Form Type: DEF 14A
Source: 0001213900-25-115783
Chunk: 33

Company: CERO THERAPEUTICS HOLDINGS, INC.
Filing Date: 2025-11-28
Form: DEF 14A
Chunk 33
---
10 trading days after such Triggering Event has been cured and permit the conversion of the Series E Preferred Stock at the “Alternate Conversion Price”. “Triggering Events” include the breach of covenants set forth in the COD, including, but not limited to, with respect to the Company’s obligation to file and maintain the effectiveness of a resale registration statement for the underlying shares of Common Stock, maintain the listing of the Common Stock on a nationally recognized securities exchange or deliver shares of Common Stock upon conversion of the Series E Preferred Stock within the required time period, as well as certain court judgments or defaults under outstanding indebtedness or events of bankruptcy or insolvency. The “Alternate Conversion Price” is either (i) the Alternate Optional Conversion Price (as defined in the COD), which is the lower of the then -currentconversion price and the greater of (a) the floor price of $1.00 (the “Floor Price”) and (b) 95% of the lowest volume -weightedaverage price of the Common Stock during the five consecutive trading day period prior to the conversion date, and/or (ii) the Alternative Triggering Event Conversion Price (as defined in the COD), which is the lower of the then -currentconversion price and the greater of (a) the Floor Price and (b) 90% of the lowest volume -weightedaverage price of the Common Stock during the five consecutive trading day period prior to the conversion date. The Alternate Conversion procedures also result in the application of a 125% Required Premium (as defined in the COD) added to the value of the Series E Preferred Stock converted. As a result, following a decline in the trading price of the Common Stock when the Alternate Conversion procedures are in effect, the Series E Preferred Stock may be convertible at a conversion price as low as the Floor Price. If all of the 9,750 shares of Series E Preferred Stock, including the 3,816 shares of Series E Preferred Stock and the 5,934 shares of Series E Preferred Stock that may be issued in additional closings, were converted at the Floor Price following an Alternate Conversion resulting in the reset of the conversion price to the Floor Price, the October 2025 Investors would own 9,750,000 shares of Common Stock, or approximately 31.9% of the outstanding shares of Common Stock. If such shares were converted at the Floor Price, with the application of the Required Premium, the October 2025 Investors would own 12,187,500 shares of Common Stock, or